Biotechnology News and Research

RSS

Protein produced by gene fusion that may also be targeted for new prostate cancer therapies

Researchers from NewYork-Presbyterian Hospital/Weill Cornell Medical Center have discovered a new gene fusion that is highly expressed in a subset of prostate cancers.

24 Jul 2009

Scientists make liquid protein

The first known example of a liquid protein has been made by chemists at the University of Bristol opening up the possibility of a number of medical and industrial applications including high-potency pharmaceuticals and protein-based coolants and lubricants.

23 Jul 2009

Costly biologics drugs prompt exclusivity debate

"A bitter Congressional fight over the cost of superexpensive biotechnology drugs has come down to a single, hotly debated number: How many years should makers of those drugs be exempt from generic competition?" The New York Times reports.

22 Jul 2009

Some health groups increase lobbying spending, but only a slight rise overall

"Drug makers, advocacy groups, biotechnology firms and insurance companies have ratcheted up efforts to offer their two cents - and in most cases much, much more - in influencing the health care legislation now working its way through Congress," The New York Times reports.

22 Jul 2009

H1N1 death toll doubles over last month; first vaccine trial begins

The worldwide death toll from the H1N1 (swine flu) virus has doubled in the past month, reaching over 700, the WHO announced Tuesday, the AP/Google.com reports.

22 Jul 2009

NovaSterilis receives patent for vaccine creation using supercritical carbon dioxide

NovaSterilis Inc., a developer of supercritical carbon dioxide technology for biomedical applications, announces the issue of US Patent 7,560,113 for creation and production of whole cell vaccines with supercritical carbon dioxide (SCCO2)*.

22 Jul 2009

New hope for the global iron deficiency problem

According to the World Health Organization, approximately two billion people suffer from iron deficiency. They tire easily, experience problems in metabolizing harmful substances in their bodies and eventually suffer from anemia.

21 Jul 2009

Potential new treatment for Alzheimer’s

Indeed, these carriers tend to develop the disease later than others, but when that happens, it progresses more rapidly and does not respond to medication. Therefore, the bottom line is that carriers of the mutated gene have a greater risk than others for disease progression.

20 Jul 2009

Bio manufacturers poised to follow Senate victory with house win

"A veteran California lawmaker with ties to the biotechnology industry said she thinks her proposal to protect brand-name biologic makers has enough support to carry in the House Energy and Commerce Committee," Dow Jones Newswires/Wall Street Journal reports.

15 Jul 2009

New drug blocks common cancer pathway

Scientists have developed a new drug which can reduce the growth of tumours in mice by up to 98 per cent, according to a study published in Molecular Cancer Therapeutics ** this week.

15 Jul 2009

HELP Committee approves protection for high tech drug companies from generics

"Senators agreed Monday to give high-tech biologic drugs 12 years of market protection before generic versions can compete," according to The Associated Press.

15 Jul 2009

Overcoming the big ‘nanotech’ challenges

Whether in the fields of medicine, sustainable energy supply or environmental protection, without making use of nanotechnology we will not be capable of overcoming the challenges which the future presents. In parallel with these efforts, though, it is essential that we examine the new technology very carefully for potential risks, such as those presented by free nanoparticles.

14 Jul 2009

Happier, healthier, more productive hens on omega-3?

Most of us are aware of the potential health benefits of omega-3 found in fish oil and flax seed. Now researchers are looking at how omega-3 may help laying hens avoid bone damage.

13 Jul 2009

Scientists step closer to first artificial nerve cell

Scientists at the Swedish medical university Karolinska Institutet and Linköping University are well on the way to creating the first artificial nerve cell that can communicate specifically with nerve cells in the body using neurotransmitters. The technology has been published in an article in Nature Materials.

7 Jul 2009

New UK national genome centre

A new UK national genome centre was officially opened by Nobel Laureate and genome pioneer Prof Sir John Sulston and the Lord-Lieutenant of Norfolk.

5 Jul 2009

Major new e-science resource for biologists

The University of Manchester and the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) have launched a major new e-science resource for biologists - which could accelerate research into treatments for H1N1 flu and cancer.

From The University of Manchester 2 Jul 2009